Publications

2022

Alves da Silva, PH; Xing, S; Kotini, AG; Papapetrou, EP; Song, X; Wucherpfennig, KW, Mascarenhas J; Ferrari de Andrade, L*. MICA/B antibody induces macrophage-mediated immunity against acute myeloid leukemia. Blood 139(2):205-216, 2022. PMID: 34359073. *Corresponding author.

Maurer, S; Zhong, X; Prada, BD; Mascarenhas, J; Ferrari de Andrade, L.* The Latest Breakthroughs in Immunotherapy for Acute Myeloid Leukemia, with a Special Focus on NKG2D Ligands. International Journal of Molecular Sciences 2022, 23(24), 15,907. PMID: 36555547. *Corresponding author.

 

2020

Xing, S; Ferrari de Andrade, L*. NKG2D and MICA/B shedding: a ‘tag game’ between NK cells and malignant cells. Clinical & Translational Immunology 9(12), e1230, 2020. PMID: 33363734. *Corresponding author.

Maurer, S*; Ferrari de Andrade, L*. NK cell interaction with platelets and myeloid cells in the tumor milieu. Frontiers in Immunology 11, Article 608849, 2020. PMID: 33424862. *Corresponding authors.

Ferrari de Andrade, L*; Kumar, S; Luoma, AM; Ito, Y; Alves da Silva, PH; Pan, D; Pyrdol, JW; Yoon, CH; Wucherpfennig, KW.* Inhibition of MICA and MICB Shedding Elicits NK cell-mediated Immunity against Tumors Resistant to Cytotoxic T cells. Cancer Immunology Research 8:769-780, 2020. PMID: 32209637. *Corresponding authors.

 

2019

Ferrari de Andrade, L*; Lu, Y*; Luoma, A; Ito, Y; Pan, D; Pyrdol, JW; Yoon, CH; Yuan, G-C; Wucherpfennig, KW. Discovery of specialized NK cell populations infiltrating human melanoma metastases. JCI Insight 2019;4(23):e133103. PMID: 31801909. *Equal authorship.

 

2018

Ferrari de Andrade, L; Tay, RE; Pan, D; Luoma, AM; Ito, Y; Badrinath, S; Tsoucas, D; Franz, B; May Jr KF; Harvey, CJ; Kobold, S; Pyrdol, JW; Yoon, C; Yuan, G-C; Hodi, FS; Dranoff, G; Wucherpfennig, KW. Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity. Science 359, 1537-1542, 2018. PMID: 29599246.

 

2015

Guillerey, C*; Ferrari de Andrade, L*; Vuckovic, S; Miles, K; Ngiow, SF; Yong, MCR; Teng, MWL; Colonna, M; Ritchie, DS; Chesi, M; Bergsagel, PL; Hill, GR; Smyth, MJ; and Martinet, L. Immunosurveillance and therapy of multiple myeloma are CD226 dependent. The Journal of Clinical Investigation 125(5), 2077-2089, 2015. PMID: 26075821. *Equal authorship.

 

2014

Ferrari de Andrade, L; Ngiow, SF; Stannard, K; Rusakiewicz, S; Kalimutho, M; Khanna, KK; Tey, S-K; Takeda, K; Zitvogel, L; Martinet, L; and Smyth, MJ. NK cells are essential for the ability of BRAF inhibitors to control BRAFV600E-mutant metastatic melanoma. Cancer Research 74(24), 7298-7308, 2014. PMID: 25351955.

Ferrari de Andrade, L; Smyth MJ; and Martinet L. DNAM-1 control of natural killer cells functions through nectin and nectin-like proteins. Immunology and Cell Biology 92, 237-244, 2014. PMID: 24343663.